ArticleJournal of the National Cancer Center2024

Establishing the homologous recombination score threshold in metastatic prostate cancer patients to predict the efficacy of PARP inhibitors.

Diwei Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.